DRUGS	sens assoc	res assoc	tot
1378 - Bleomycin (50 uM) [DNA damage]	1	17	18
1047 - Nutlin-3a [MDM2]	1	14	15
208 - SB-715992 [KIF11]	1	10	11
1175 - AG-014699 [PARP1, PARP2]	1	8	9
179 - 5-Fluorouracil [DNA antimetabolite]	0	9	9
300 - CX-5461 [RNA Pol I]	3	6	9
1003 - Camptothecin [TOP1]	1	6	7
1054 - PD-0332991 [CDK4, CDK6]	1	6	7
1012 - Vorinostat [HDAC inhibitor Class I, IIa, IIb, IV]	0	6	6
1239 - YK 4-279 [RNA helicase A]	0	6	6
257 - NPK76-II-72-1 [PLK3]	2	4	6
1009 - ATRA [Retinoic acid and retinoid X receptor agonist]	2	3	5
1014 - RDEA119 [MAP2K1 (MEK1), MAP2K2 (MEK2)]	4	1	5
1015 - CI-1040 [MAP2K1 (MEK1), MAP2K2 (MEK2)]	3	2	5
1050 - ZM-447439 [AURKB]	1	4	5
1057 - NVP-BEZ235 [PI3K (Class 1) and MTORC1/2]	0	5	5
110 - Roscovitine [CDKs]	0	5	5
1129 - PF-4708671 [RPS6KB1 (p70S6KA)]	0	5	5
1242 - (5Z)-7-Oxozeaenol [MAP3K7 (TAK1)]	1	4	5
1498 - AZD6244 [MAP2K1 (MEK1), MAP2K2 (MEK2)]	4	1	5
1526 - RDEA119 (rescreen) [MAP2K1 (MEK1), MAP2K2 (MEK2)]	3	2	5
230 - GSK429286A [ROCK2]	5	0	5
272 - AR-42 [HDAC]	1	4	5
290 - KIN001-260 [IKK]	3	2	5
326 - GSK690693 [AKT]	5	0	5
330 - XMD13-2 [RIPK]	2	3	5
1013 - Nilotinib [ABL]	4	0	4
1021 - Axitinib [PDGFR, KIT, VEGFR]	3	1	4
1024 - CEP-701 [FLT3, JAK2, NTRK1, RET]	0	4	4
1049 - PD-173074 [FGFR1, FGFR3]	1	3	4
1149 - TW 37 [BCL2, BCL2L1]	0	4	4
1259 - BMN-673 [PARP1]	1	3	4
1372 - Trametinib [MAP2K1 (MEK1), MAP2K2 (MEK2)]	3	1	4
152 - CP466722 [ATM]	1	3	4
157 - JNK-9L [JNK]	0	4	4
182 - Obatoclax Mesylate [BCL2, BCL2L1, MCL1]	0	4	4
200 - LAQ824 [HDAC]	0	4	4
254 - AC220 [FLT3]	4	0	4
255 - CP724714 [ERBB2]	3	1	4
266 - Zibotentan, ZD4054 [Endothelin A Receptor]	2	2	4
287 - KIN001-244 [PDPK1 (PDK1)]	2	2	4
310 - YM201636 [FYV1]	2	2	4
345 - KIN001-270 [CDK9]	2	2	4
1004 - Vinblastine [Microtubules]	0	3	3
1005 - Cisplatin [DNA crosslinker]	0	3	3
1010 - Gefitinib [EGFR]	3	0	3
1011 - ABT-263 [BCL2, BCL2L1, BCL2L2]	1	2	3
1026 - 17-AAG [HSP90]	0	3	3
1029 - AMG-706 [VEGFR, RET, c-KIT, PDGFR]	3	0	3
1170 - CCT018159 [HSP90]	0	3	3
1230 - IOX2 [EGLN1]	3	0	3
1236 - UNC0638 [G9a(EHMT2), GLP(EHMT1)]	2	1	3
133 - Doxorubicin [DNA intercalating]	0	3	3
1494 - SN-38 [TOP1]	1	2	3
1495 - AZD-2281 [PARP1, PARP2]	2	1	3
192 - LFM-A13 [BTK]	2	1	3
201 - Epothilone B [Microtubules]	0	3	3
206 - Ruxolitinib [JAK1, JAK2, TYK2]	3	0	3
221 - TAK-715 [p38a]	1	2	3
222 - BX-912 [PDPK1 (PDK1)]	3	0	3
225 - Genentech Cpd 10 [AURKA, AURKB]	2	1	3
226 - GSK1070916 [AURKB]	2	1	3
249 - XL-184 [VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, Tie2,AXL]	2	1	3
252 - WZ3105 [CLK2, CNSK1E, FLT3, ULK1]	1	2	3
260 - NG-25 [MAP3K7 (TAK1)]	3	0	3
268 - YM155 [BIRC5 (Survivin)]	1	2	3
271 - VNLG/124 [HDAC, RAR ]	3	0	3
277 - ABT-869 [VEGFR and PDGFR family]	3	0	3
281 - CH5424802 [ALK]	3	0	3
292 - Masitinib [KIT]	1	2	3
294 - MPS-1-IN-1 [MPS1]	2	1	3
295 - NVP-BHG712 [EPHB4]	3	0	3
298 - OSI-930 [KIT, VEGFR, PDGFR]	1	2	3
30 - Sorafenib [PDGFRA, PDGFRB, KDR, KIT, FLT3]	3	0	3
304 - SB52334 [ALK5]	3	0	3
328 - SNX-2112 [HSP90]	2	1	3
333 - T0901317 [LXR]	2	1	3
346 - THZ-2-102-1 [CDK7]	2	1	3
89 - Parthenolide [NFKB1]	2	1	3
1008 - Methotrexate [Dihydrofolate reductase (DHFR)]	0	2	2
1016 - Temsirolimus [MTOR]	1	1	2
1017 - Olaparib [PARP1, PARP2]	1	1	2
1018 - ABT-888 [PARP1, PARP2]	1	1	2
1019 - Bosutinib [SRC, ABL, TEC]	2	0	2
1028 - VX-702 [p38]	2	0	2
1031 - Elesclomol [HSP70]	1	1	2
1032 - Afatinib [ERBB2, EGFR]	2	0	2
1033 - Vismodegib [SMO]	1	1	2
1036 - PLX4720 [BRAF]	2	0	2
1039 - SL 0101-1 [RSK, AURKB, PIM3]	0	2	2
1046 - 681640 [WEE1, CHEK1]	0	2	2
1060 - PD-0325901 [MAP2K1 (MEK1), MAP2K2 (MEK2)]	2	0	2
1066 - AZD6482 [PI3Kbeta]	0	2	2
1091 - BMS-536924 [IGF1R]	0	2	2
1133 - JNJ-26854165 [MDM2]	0	2	2
1142 - HG-5-113-01 [LOK, LTK, TRCB, ABL(T315I)]	1	1	2
1143 - HG-5-88-01 [EGFR, ADCK4]	1	1	2
1166 - QL-VIII-58 [MTOR, ATR]	0	2	2
119 - Lapatinib [ERBB2, EGFR]	2	0	2
1243 - piperlongumine [Increases ROS levels]	0	2	2
1248 - FK866 [NAMPT]	1	1	2
1264 - SGC0946 [Q8TEK3 (DOT1L)]	2	0	2
136 - Mitomycin C [DNA crosslinker]	1	1	2
1373 - Dabrafenib [BRAF]	1	1	2
140 - Vinorelbine [Microtubules]	0	2	2
147 - NSC-87877 [PTPN6 (SHP-1), PTPN11 (SHP-2)]	2	0	2
1529 - MLN4924 [NEDD8-activating enzyme]	0	2	2
155 - AP-24534 [ABL]	1	1	2
178 - BAY 61-3606 [SYK]	0	2	2
184 - BMS-754807 [IGF1R]	1	1	2
185 - OSI-906 [IGF1R]	2	0	2
194 - AUY922 [HSP90]	0	2	2
231 - FMK [RSK]	1	1	2
261 - TL-1-85 [MAP3K7 (TAK1)]	2	0	2
263 - FR-180204 [ERK]	2	0	2
274 - PXD101, Belinostat [HDAC]	1	1	2
302 - PI-103 [PI3Ka, PRKDC (DNAPK)]	2	0	2
303 - PIK-93 [PI4K, PI3K]	2	0	2
305 - TPCA-1 [IKK]	2	0	2
306 - TG101348 [JAK2]	0	2	2
312 - AV-951 [VEGFR]	2	0	2
38 - AZD-0530 [SRC, ABL1]	2	0	2
45 - Z-LLNle-CHO [g-secretase]	0	2	2
5 - Sunitinib [PDGFRA, PDGFRB, KDR, KIT, FLT3]	2	0	2
60 - BI-2536 [PLK1, PLK2, PLK3]	0	2	2
94 - TGX221 [PI3Kbeta]	2	0	2
1 - Erlotinib [EGFR]	1	0	1
1001 - AICAR [AAPK1 (AMPK) agonist]	0	1	1
1006 - Cytarabine [DNA synthesis]	1	0	1
1007 - Docetaxel [Microtubules]	0	1	1
1020 - Lenalidomide [TNFA]	0	1	1
1022 - AZD7762 [CHEK1, CHEK2]	0	1	1
1023 - GW 441756 [NTRK1]	1	0	1
1037 - BX-795 [TBK1, PDPK1, IKK, AURKB, AURKC]	0	1	1
104 - Bortezomib [Proteasome]	0	1	1
1042 - BIRB 0796 [p38, JNK2]	0	1	1
1061 - SB590885 [BRAF]	1	0	1
1114 - Cetuximab [EGFR]	1	0	1
1161 - ZG-10 [IRAK1]	0	1	1
1219 - PFI-1 [BRD2, BRD3, BRD4]	0	1	1
134 - Etoposide [TOP2]	1	0	1
135 - Gemcitabine [DNA replication]	1	0	1
1371 - PLX4720 (rescreen) [BRAF]	1	0	1
1375 - Temozolomide [DNA akylating agent]	0	1	1
1377 - Afatinib (rescreen) [ERBB2, EGFR]	1	0	1
1527 - GDC0941 (rescreen) [PI3K]	1	0	1
159 - HG-6-64-1 [BRAFV600E, TAK, MAP4K5]	1	0	1
166 - FTI-277 [Farnesyl transferase (FNTA)]	1	0	1
167 - OSU-03012 [PDPK1 (PDK1)]	0	1	1
171 - AKT inhibitor VIII [AKT1, AKT2, AKT3]	0	1	1
172 - Embelin [XIAP]	0	1	1
176 - IPA-3 [PAK1, PAK2, PAK3]	0	1	1
180 - Thapsigargin [sarco-endoplasmic reticulum Ca2+-ATPases]	0	1	1
186 - Bexarotene [Retinioic acid X family agonist]	1	0	1
193 - GW-2580 [CSF1R (cFMS)]	1	0	1
197 - Bryostatin 1 [PRKC]	1	0	1
199 - Pazopanib [VEGFR, PDGFRA, PDGFRB, KIT]	1	0	1
203 - BMS-345541 [IKBKB]	1	0	1
204 - Tipifarnib [Farnesyl-transferase (FNTA)]	0	1	1
207 - AS601245 [JNK ]	0	1	1
211 - TL-2-105 [CRAF]	1	0	1
219 - AT-7519 [CDK9]	1	0	1
223 - ZSTK474 [PI3K]	1	0	1
228 - KIN001-102 [AKT1]	1	0	1
229 - LY317615 [PRKCB (PKCbeta)]	0	1	1
238 - CAL-101 [PI3Kdelta]	1	0	1
245 - UNC0638 [G9a(EHMT2), GLP(EHMT1)]	0	1	1
253 - XMD14-99 [EPHB3, CAMK1]	1	0	1
256 - JW-7-24-1 [LCK]	1	0	1
258 - STF-62247 [stimulates autophagy]	1	0	1
262 - VX-11e [ERK]	1	0	1
265 - Tubastatin A [HDAC6]	1	0	1
273 - CUDC-101 [HDAC, EGFR]	1	0	1
275 - I-BET [BRD2, BRD3, BRD4]	1	0	1
276 - CAY10603 [HDAC6]	1	0	1
279 - BIX02189 [MAP2K5 (MEK5)]	1	0	1
282 - EKB-569 [EGFR]	0	1	1
283 - GSK2126458 [PI3K, MTOR]	1	0	1
286 - KIN001-236 [TIE2]	1	0	1
288 - KIN001-055 [JAK3, MNK1]	1	0	1
29 - AZ628 [BRAF]	1	0	1
291 - KIN001-266 [MAP3K8 (COT)]	1	0	1
299 - OSI-027 [MTORC1/2]	1	0	1
3 - Rapamycin [MTOR]	1	0	1
301 - PHA-793887 [CDK-pan]	1	0	1
308 - XL-880 [MET]	0	1	1
309 - Y-39983 [ROCK]	0	1	1
32 - VX-680 [AURKA, AURKB, AURKC, FLT3, ABL1, JAK2]	1	0	1
329 - QL-XI-92 [DDR1]	0	1	1
331 - QL-X-138 [MNK2, PRKDC (DNAPK), MTOR, BTK, JAK3]	1	0	1
332 - XMD15-27 [CAMK2B, CLK2, DYRK1A, MAST1, STK39]	1	0	1
34 - Imatinib [ABL, KIT, PDGFR]	1	0	1
341 - EX-527 [SIRT1]	1	0	1
344 - THZ-2-49 [CDK9]	1	0	1
37 - Crizotinib [MET, ALK]	1	0	1
51 - Dasatinib [ABL, SRC, KIT, PDGFR]	1	0	1
52 - GNF-2 [ABL [T315I]]	1	0	1
53 - CGP-60474 [CDK1,CDK2,CDK5,CDK7,CDK9]	0	1	1
55 - A-770041 [SRC family]	1	0	1
56 - WH-4-023 [SRC family, ABL]	1	0	1
59 - WZ-1-84 [BMX]	1	0	1
63 - BMS-509744 [ITK]	1	0	1
71 - Pyrimethamine [Dihydrofolate reductase (DHFR)]	1	0	1
86 - A-443654 [AKT1, AKT2, AKT3]	0	1	1
87 - GW843682X [PLK1]	0	1	1
9 - MG-132 [Proteasome]	0	1	1